CLIENTS

• AMPLITUDE TECHNOLOGIES – advanced solid-state lasers

www.amplitude-technologies.com

 
• ARIANA PHARMA – decision support
"Boston is a privileged location to establish and develop relationships with prospects and clients. Throughout the seminars and contacts that Hubtech21 has been organizing for us, the US have become a major share in Ariana's activities." Mohammad Afshar, CEO Ariana Pharma

www.arianapharma.com

 
• BIOCORTECH – drug development for psychiatric disorders

www.biocortech.com/

 
• BIOMETHODES – protein optimization

www.biomethodes.com

 
• BIOPROTEIN TECHNOLOGIES – protein production

www.bioprotein.com

 
• ESSONNE DEVELOPMENT AGENCY – economic development support to companies

www.essonne-developpement.com

 
• GENOMIC VISION – new diagnostics tools

www.genomicvision.com

 
• GENOPOLE - France’s leading Biotech cluster

www.genopole.com

 
• HYBRIGENICS – protein-protein Interaction detection
« The quality of organization and contact opportunities delivered match our ambitions. »
Didier Petiteville, Director of Operations Hybrigenics

www.hybrigenics.com

 
• HGH INFRARED SYSTEMS -manufacturer of optronic and infrared systems for defense, industrial and civil applications

www.hgh.fr/index-en.php

 
• IMAGINE OPTIC – Shack-Hartmann wavefront sensing technologies for adaptive optics

www.imagine-optic.com

 
• INSTITUT PASTEUR – Business Development and technology transfer department

www.pasteur.fr

 
• MAUNA KEA TECHNOLOGIES – imaging systems
« The Boston Office is the perfect base of operations for our development in the US. »
Benjamin Abrat, co-founder & Vice-President Mauna Kea Technologies

www.maunakeatech.com

 
• MERISTEM Protein production

www.meristem-therapeutics.com

 
• NOKAD – functional KO models in any mammalian species

www.nokad-technology.com

 
• PARIS REGION ECONOMIC DEV. AGENCY – assistance in business settlements

www.paris-region.com

 
• SINOVIA –Systems interoperability, hypervision

www.sinovia.com

 
• UROGENE – urology drug discovery
 
• WATCHFROG - in vivo detection of chemical, pharmaceutical and cosmetic substances

www.watchfrog.fr

 
• ZETA BIOTECH is a French young innovative
company listed on Euronext since July 2007.
ZETA BIOTECH’s core competency is a new
patented technology to preserve biomolecules
and other products which can be used in
several domains such as pharmaceutical
industry, cosmetics, nutrition and
biotechnology.
The first product of ZETA BIOTECH is a unique
electrophoresis precast gel with a reproductibility level significantly higher than existing gels.

www.zetabiotech.com

 
• Cellectis is the worldwide leader in the research, development and commercialization of rational genome engineering technologies. Cellectis proprietary technologies and platform are based upon a naturally occurring class of DNA endonucleases, the Meganucleases and DNA recombination.

www.cellectis.com

 
NEWS
& Events
Tuesday, October 07, 2008
EUROBIO 2008: meet Hubtech21
Patrick Cheenne, CEO of Hubtech21, will be present at Eurobio 2008, October 7th-9th at Palais des Congrθs in Paris,
Tuesday, September 30, 2008
Hubtech21 at OPTO 2008
Date : Sept.30th – October 2nd
Place : Paris Nord – Villepinte, France

Once again this year, Hubtech21 will be
Monday, September 29, 2008
WSJ 2008 innovation award for Mauna Kea Technologies

Mauna Kea Technologies, who used Hubtech21's services and facilities to grow their
Monday, September 15, 2008
Sales Manager – North America

JOB CODE: DSNA
LOCATION: Boston, Massachusetts or any location in the East Coast.

COMPANY
Quantel